Jaguar Health (JAGX) Receivables - Other (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Receivables - Other of $212000.0 for Q1 2026, up 27.71% year-over-year from $166000.0 in Q1 2025, and up 96.3% quarter-over-quarter from $108000.0 in Q4 2025.
Jaguar Health (JAGX) Receivables - Other (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Receivables - Other for 12 consecutive years, with $212000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other rose 27.71% year-over-year to $212000.0; the TTM figure through Mar 2026 stood at $212000.0 (up 27.71% YoY), while the FY2025 annual figure was $177000.0, up 47.5% from the prior year.
- Receivables - Other advanced to $212000.0 in Q1 2026 per JAGX's latest filing, from $108000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $634000.0 in Q3 2022 and bottomed at -$85000.0 in Q4 2022.
- Historically, Receivables - Other has averaged $202882.4 across 5 years, with a median of $161000.0 in 2023.
- On a YoY basis, Receivables - Other climbed as much as 1433.33% in 2022 and fell as far as 124.93% in 2022.
- Jaguar Health's Receivables - Other stood at -$85000.0 in 2022, then surged by 136.47% to $31000.0 in 2023, then jumped by 138.71% to $74000.0 in 2024, then soared by 45.95% to $108000.0 in 2025, then jumped by 96.3% to $212000.0 in 2026.
- Business Quant data shows JAGX's Receivables - Other at $212000.0 in Q1 2026, $108000.0 in Q4 2025, and $67000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - |
| 10 | Jaguar Health | 458,638.68 | -9.61 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |